Skip to main content
TipRanks
Go Ultimate75% OFF

JCR Pharmaceuticals Co., Ltd. (4552) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

4552 Analyst Ratings

Moderate Buy
3Ratings
1Buy2Hold0Sell
Based on 3 analysts giving stock ratings to JCR Pharmaceuticals Co., Ltd. in the past 3 months

4552 Stock 12 Month Forecast

¥766.67▲(53.64% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for JCR Pharmaceuticals Co., Ltd. in the last 3 months. The average price target is JPY 766.67 with a high forecast of JPY 1,200.00 and a low forecast of JPY 540.00. The average price target represents a 53.64% change from the last price of JPY 499.00.
Highest Price Target¥1,200Average Price Target¥766.67Lowest Price Target¥540.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for JP:4552
Price TargetArticle
Mizuho Securities Analyst forecast on JP:4552Unknown AnalystNot RankedMizuho Securities¥1,200buy140.48%UpsideReiterated10/09/26
Citi Analyst forecast on JP:4552Unknown AnalystNot RankedCiti¥560hold12.22%UpsideReiterated08/27/26
Nomura Analyst forecast on JP:4552Unknown AnalystNot RankedNomura¥430→¥540hold8.22%UpsideReiterated08/18/26
Daiwa Analyst forecast on JP:4552Unknown AnalystNot RankedDaiwa¥540hold8.22%UpsideReiterated06/25/26
Morgan Stanley Analyst forecast on JP:4552Unknown AnalystNot RankedMorgan Stanley¥500hold0.20%UpsideReiterated06/09/26
SBI Securities Analyst forecast on JP:4552Unknown AnalystNot RankedSBI Securities¥450hold-9.82%DownsideReiterated06/04/26
Jefferies¥900buy80.36%UpsideUpgraded04/16/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HROWHarrow Health
PLSEPulse Biosciences
DFTXDefinium Therapeutics
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering JCR Pharmaceuticals Co., Ltd.

3 Months
Success Rate0/1 ratings generated profit
0%
Average Return
-8.50%

Copying Miyabi Yamakita's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -8.50% per trade.

1 Year
Success Rate0/1 ratings generated profit
0%
Average Return
-12.80%

Copying Miyabi Yamakita's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.80% per trade.

2 Years
Success Rate0/1 ratings generated profit
0%
Average Return
-12.80%

Copying Miyabi Yamakita's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -12.80% per trade.

4552 Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 4552
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00011
Buy00000
Hold56220
Sell00000
Strong Sell00000
total56231

In the current month, 4552 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 4552 average Analyst price target in the past 3 months is 766.67.

4552 Financial Forecast

¥-18¥-12.5¥-7¥-1.5¥4Q4 2025Q2 2026Q3 2026
High¥-13.83
Consensus¥-13.83
Low¥-13.83

4552 Earnings Forecast

Next quarter’s earnings estimate for 4552 is -JPY 13.83 with a range of -JPY 13.83 to -JPY 13.83. The previous quarter’s EPS was -JPY 16.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

¥9B¥10.1B¥11.3B¥12.4B¥13.6BQ4 2025Q2 2026Q3 2026
High¥13.6B
Consensus¥11.9B
Low¥10.2B

4552 Sales Forecast

Next quarter’s sales forecast for 4552 is JPY 11.91B with a range of JPY 10.23B to JPY 13.59B. The previous quarter’s sales results were JPY 10.27B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

4552 Stock Forecast FAQ

What is JP:4552’s average 12-month price target, according to analysts?
Based on analyst ratings, JCR Pharmaceuticals Co., Ltd.’s 12-month average price target is ¥766.67.
What is JP:4552’s upside potential, based on the analysts’ average price target?
JCR Pharmaceuticals Co., Ltd. has 53.64% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is JCR Pharmaceuticals Co., Ltd. a Buy, Sell or Hold?
JCR Pharmaceuticals Co., Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 2 hold ratings and 0 sell ratings.
What is JCR Pharmaceuticals Co., Ltd.’s share price target?
The average share price target for JCR Pharmaceuticals Co., Ltd. is ¥766.67. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is ¥1,200.00, and the lowest forecast is ¥540.00. The average share price target represents a 53.64% increase from the current price of ¥499.
What do analysts say about JCR Pharmaceuticals Co., Ltd.?
JCR Pharmaceuticals Co., Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of JCR Pharmaceuticals Co., Ltd.?
To buy shares of JP:4552, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.